INNV Stock Analysis: Buy, Sell, or Hold?
INNV - InnovAge Holding Corp. Common Stock
$9.21
0.24 (2.68%)
▲
5d:
+1.1%
30d:
+22.64%
90d:
+18.84%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Sep 08, 2026
Get Alerted When INNV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: INNV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: INNV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.01
Based on 4.8% avg growth
INTRINSIC VALUE TODAY
$7.46
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INNV is currently trading at $9.21, which is considered extended relative to its 30-day fair value range of $7.06 to $8.71. The stock's valuation (Forward PE: 24.2) is in line with its historical norms (26.4). Remarkably, the market is currently pricing in an annual earnings decline of 2.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, INNV is showing sideways momentum. The price is approaching resistance at $7.74. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INNV has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (14th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $7.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INNV is showing sideways momentum. The price is approaching resistance at $7.74. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INNV has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (14th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $7.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$7.06 -
$8.71
Company Quality Score
57/100
(HOLD)
Options IV Signal
14th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
57.7%
All Signals
- BEARISH: Price extended above range (+5.7% above its trading range)
- BULLISH: Options cheap (IV 14th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 24.0% above Wall St target ($7.00)
Trading Range Analysis
30-Day Trading Range
$7.06 -
$8.71
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$1.19
(12.9%)
Support & Resistance Levels
Support Level
$7.04
Resistance Level
$7.74
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.24
Wall Street Target
$7.00
(-24.0%)
Revenue Growth (YoY)
15.5%
Earnings Growth (YoY)
-87.8%
Profit Margin
-1.2%
Valuation Discount vs History
-2.8% cheaper
PE vs Historical
24.2 vs 26.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.8%
(market-implied from PE analysis)
1-Year Target
$8.95
(-3%)
2-Year Target
$8.70
(-6%)
3-Year Target
$8.46
(-8%)
3-Yr Target (if PE normalizes)
(PE: 24→26)
$9.21
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.2, Growth: 5.6%)
$10.83
(+18%)
Base:
(SPY PE: 21.8, Growth: 5.6%)
$9.73
(+6%)
Bear:
(PE: 18.5, Growth: 5.6%)
$8.27
(-10%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 24.2 to 26.4
Stabilization Target:
$10.03
(+8.9%)
PE Expansion Potential:
+8.9%
Share & Embed Analysis
Last updated: June 23, 2026 9:21 AM ET
Data refreshes hourly during market hours. Next update: 10:21 AM
Data refreshes hourly during market hours. Next update: 10:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INNV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 60 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 54 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 58 HOLD |
